0

Language Models are Surprisingly Fragile to Drug Names in Biomedical Benchmarks

A new dataset evaluates the robustness of LLMs in medical benchmarks by swapping brand and generic drug names, revealing performance drops attributed to test data contamination in pre-training datasets.

Year
2024
Venue
arXiv 2024
Authors
10
Hosting
Abstract onlyARXIV-DEFAULT

Cite

Notes

Only stored in your browser.

Attribution

Abstract & full text
arxiv.org/abs/2406.12066v2ARXIV-DEFAULT
TL;DR
Semantic Scholar
Attribution policy →

Abstract

Medical knowledge is context-dependent and requires consistent reasoning across various natural language expressions of semantically equivalent phrases. This is particularly crucial for drug names, where patients often use brand names like Advil or Tylenol instead of their generic equivalents. To study this, we create a new robustness dataset, RABBITS, to evaluate performance differences on medical benchmarks after swapping brand and generic drug names using physician expert annotations. We assess both open-source and API-based LLMs on MedQA and MedMCQA, revealing a consistent performance drop ranging from 1-10%. Furthermore, we identify a potential source of this fragility as the contamination of test data in widely used pre-training datasets. All code is accessible at https://github.com/BittermanLab/RABBITS, and a HuggingFace leaderboard is available at https://huggingface.co/spaces/AIM-Harvard/rabbits-leaderboard.

Authors

10